menu
    • menu

    Company profile for MERIAL CANADA INC

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MERIAL CANADA INCCanada Flag
    Country
    Country
    Canada
    Address
    Address
    20000 CLARK GRAHAM
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.boehringer-ingelheim.com/animal-health?merial=true
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. FTC Requires Divestitures In $13.53 Bln Boehringer Ingelheim - Sanofi Deal
    U.S. FTC Requires Divestitures In $13.53 Bln Boehringer Ingelheim - Sanofi Deal

    29 Dec 2016

    // NASDAQ

    http://www.nasdaq.com/article/us-ftc-requires-divestitures-in-1353-bln-boehringer-ingelheim--sanofi-deal-20161228-00347

    NASDAQ
    29 Dec 2016
    Share Share
    Boehringer Gains Conditional EU Okay to Buy Sanofi Unit
    Boehringer Gains Conditional EU Okay to Buy Sanofi Unit

    10 Nov 2016

    // Foo Yun Chee REUTERS

    http://www.reuters.com/article/us-sanofi-fr-m-a-boehringer-eu-idUSKBN1342WI

    Foo Yun Chee REUTERS
    10 Nov 2016
    Share Share
    Sanofi puts 2 units on the block, commits to $1.6B in cuts to turn business
    Sanofi puts 2 units on the block, commits to $1.6B in cuts to turn business

    07 Nov 2015

    // Nick Paul Taylor FIERCE PHARMA

    http://www.fiercepharma.com/story/sanofi-puts-2-units-block-commits-16b-cuts-turn-business-around/2015-11-06

    Nick Paul Taylor FIERCE PHARMA
    07 Nov 2015
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search